Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Spiolto Respimat 2.5microg/dose/2.5microg/dose soln
0301040X0BBAAAA
|
Spiolto Respimat | Tiotropium bromide/olodaterol | Respiratory System | 67,899 |
|
Spiolto Respimat 2.5microg/dose / 2.5microg/dose soln refill
0301040X0BBABAB
|
Spiolto Respimat | Tiotropium bromide/olodaterol | Respiratory System | 34,277 |
|
Tiotropium brom 2.5microg/Olodaterol 2.5microg/dose soln&dev
0301040X0AAAAAA
|
Tiotropium bromide/olodaterol | Tiotropium bromide/olodaterol | Respiratory System | 6,491 |
|
Tiotropium brom 2.5microg/Olodaterol 2.5microg/dose soln
0301040X0AAABAB
|
Tiotropium bromide/olodaterol | Tiotropium bromide/olodaterol | Respiratory System | 2,343 |
|
Yanimo Respimat 2.5microg/dose / 2.5microg/dose soln
0301040X0BCAAAA
|
Yanimo Respimat | Tiotropium bromide/olodaterol | Respiratory System | 7 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.